EN
HI
Ind-Swift Laboratories Share price
INDSWFTLAB
327.27
0.00 (0.00%)NSE
BSE
Last updated on 24 Aug, 2026 | 15:31 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Ind-Swift Laboratories share price chart
Ind-Swift Laboratories Share Key Metrics
Volume
4.33 L
Market Cap
2841.90 CR
LTQ@LTP
334@327.27
ATP
325.8
Var Margin
100 %
Circuit Range
261.82-392.72
Delivery %
36.18 %
Value
14.11 CR
ASM/GSM
No
Market Lot
1
Summary
INDSWFTLAB stock price is ₹327.27 as of 25 Aug, 2026. The stock intraday movement has stayed between ₹316.61 and ₹332.31, while Ind-Swift Laboratories share price 52 week high low is ₹87.15 & ₹351.30.
In terms of trading activity, INDSWFTLAB share price has recorded a volume of 4,33,051 shares. The Ind-Swift Laboratories has a market cap of ₹86836558. The stock’s Average Traded Price (ATP) stands at ₹325.80, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 334 @ ₹327.27.
The Ind-Swift Laboratories upper circuit limit is ₹392.72 & The Ind-Swift Laboratories lower circuit limit is ₹261.82, with a Value of ₹14.11 CR. The Delivery Percentage for the day is 36.18%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Ind-Swift Laboratories Resistance and Support
Pivot 325.4
Resistance
First Resistance
334.19
Second Resistance
341.1
Third Resistance
349.89
Support
First Support
318.49
Second Support
309.7
Third Support
302.79
Ind-Swift Laboratories Shareholding Pattern
View More- 2016-17
- 2017-18
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
42.93%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
10.7%
Domestic Institutional Investors
0.17%
Retail
46.2%
Others
0%
Total Promoters
MAR '26
42.99%
JUN '26
42.93%
Ind-Swift Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-07-10 | To consider issue of Warrants |
| 2026-05-28 | Audited Results |
| 2026-01-31 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-13 | Quarterly Results |
| 2025-02-12 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
Ind-Swift Laboratories News
Ind-Swift Laboratories Ltd - 532305 - Audio Recording Of Earning Conference Call Held On 17.08.2026.
Ind Swift Laboratories announced the availability of its Q1 FY27 earnings conference call audio recording, held on August 17, 2026. This allows investors to access the discussion on financial results. The transcript will also be made available soon.
Aug 17 2026 19:05:28
Ind-Swift Laboratories Ltd - 532305 - Statement Of NIL Deviation Or Variation Under Reg. 32
Ind Swift Laboratories confirmed that Rs.58.99 crore from its preferential issue of convertible warrants was not realized. This shortfall occurred because an allottee failed to convert their warrants into equity within the stipulated time.
Aug 10 2026 19:29:54
Ind-Swift Laboratories Ltd - 532305 - Shareholder Meeting / Postal Ballot-Outcome of EGM
Ind Swift Laboratories' Extra-Ordinary General Meeting (EGM) on August 5, 2026, approved the preferential allotment of up to 70 lakh fully convertible warrants. These warrants will be issued to entities belonging to the company's promoter and promoter group.
Aug 05 2026 18:51:11
Ind-Swift Laboratories Ltd - 532305 - Board Meeting Intimation for Meeting To Be Held On August 10, 2026.
Ind Swift Laboratories board will convene on August 10, 2026, to review and approve the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026.
Aug 03 2026 17:10:46
Ind-Swift Laboratories Ltd - 532305 - Corrigendum To The Notice Of 01/2026-27 Extra-Ordinary General Meeting ('EGM Notice') Dated July 10, 2026
Ind Swift Laboratories provided clarity on the utilization of Rs.137.20 crore to be raised through a preferential issue of fully convertible warrants. The funds are earmarked for business expansion, R&D, technology upgradation, investment in a subsidiary, and working capital.
Jul 29 2026 18:37:46
Ind-Swift Laboratories Ltd - 532305 - Outcome Of The Preferential Issue Committee Of The Board Of Directors Of Ind-Swift Laboratories Limited In Terms Of The Provisions Of Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Ind Swift Laboratories' Preferential Issue Committee met on July 29, 2026, and approved a corrigendum to the EGM notice. This EGM, scheduled for August 5, 2026, will seek shareholder approval for a proposed preferential issue of fully convertible warrants.
Jul 29 2026 17:45:26
Read More
Ind-Swift Laboratories Management
| Name | Position |
|---|---|
| Pardeep Verma | VP-Corp. Affairs, Company Secretary & Compliance Officer |
| Navrattan Munjal | Chairman & Managing Director |
Ind-Swift Laboratories Similar Stocks
Indraprastha Medical Corporation Ltd.
371.90
0.00 (0.00%)
Unichem Laboratories Ltd.
509.80
0.00 (0.00%)
Advanced Enzyme Technologies Ltd.
302.35
0.00 (0.00%)
SMS Pharmaceuticals Ltd.
354.10
0.00 (0.00%)
Solara Active Pharma Sciences Ltd.
629.10
0.00 (0.00%)
Dishman Carbogen Amcis Ltd.
173.25
0.00 (0.00%)
Hikal Ltd.
211.99
0.00 (0.00%)
Beta Drugs Ltd.
2307.00
0.00 (0.00%)
Panacea Biotec Ltd.
406.20
0.00 (0.00%)
Dr Agarwals Eye Hospital Ltd.
5373.50
0.00 (0.00%)
Ind-Swift Laboratories FAQs
The Buying Price of Ind-Swift Laboratories share is 327.27 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Ind-Swift Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Ind-Swift Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Ind-Swift Laboratories shares is 49.64. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Ind-Swift Laboratories shares is 1.9. Useful to assess the stock's value relative to its book value.
To assess Ind-Swift Laboratories’s valuation compare Sector P/E, P/B which are 69.22 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Ind-Swift Laboratories is 2841.90 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Ind-Swift Laboratories share price is 351.30 & 87.15. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Ind-Swift Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in INDSWFTLAB
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in INDSWFTLAB
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade